Alkylating agents: all 3,295 studies that test it

Page 14 of 33. Open to participants first (456), then studies with results posted, then the rest; newest registration first within each.

• Myeloablative Umbilical Cord Blood Transplantation in Hematological DiseasesCompletedNCT00309842Phase 2Results posted
• Bortezomib Followed by High-Dose Melphalan and Bortezomib as Conditioning Regimen for Tandem Stem Cell TransplantsCompletedNCT00307086Phase 2Results posted
• Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaCompletedNCT00305864Phase 1/2Results posted
• Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic CancerCompletedNCT00305760Phase 2Results posted
• Allogeneic Bone Marrow Transplantation Using Less Intensive TherapyTerminatedNCT00303719Phase 2Results posted
• Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain TumorsCompletedNCT00302159Phase 2Results posted
• Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's LymphomaCompletedNCT00302003Phase 3Results posted
• Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic DisordersCompletedNCT00301834Phase 2Results posted
• Phase I/II Study of High-Dose Calcitriol Plus Temodar for Patients With Metastatic MelanomaCompletedNCT00301067Phase 1/2Results posted
• Trial of Adjuvant Chemotherapy for Gastric CancerCompletedNCT00296322Phase 3Results posted
• Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's LymphomaCompletedNCT00295932Phase 1/2Results posted
• Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell TransplantCompletedNCT00293384Not applicableResults posted
• Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell LymphomaCompletedNCT00290433Phase 2Results posted
• Rheumatoid Arthritis:Tolerance Induction by Mixed ChimerismTerminatedNCT00282412Phase 1Results posted
• Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic CancerTerminatedNCT00281879Phase 2Results posted
• Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic LeukemiaCompletedNCT00280241Phase 2Results posted
• Stem Cell Transplantation in Idiopathic Inflammatory Myopathy DiseasesTerminatedNCT00278564Phase 1Results posted
• Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's LymphomaCompletedNCT00278161Phase 2Results posted
• Partial Breast Irradiation With ChemotherapyCompletedNCT00278109Phase 1/2Results posted
• Individualized Drug Treatment for Treating Patients With Pancreatic CancerTerminatedNCT00276744Phase 2Results posted
• O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem TumorsCompletedNCT00275002Phase 2Results posted
• Donor Peripheral Stem Cell Transplant in Treating Patients With Relapsed Acute Myeloid LeukemiaCompletedNCT00274846Phase 2Results posted
• A Study of Mitomycin C, Irinotecan, and CetuximabTerminatedNCT00271011Phase 2Results posted
• Safety and Tolerability of Low-Dose Temozolomide During Whole Brain Radiation in Patients With Cerebral Metastases From Non-Small-Cell Lung Cancer (Study P04071)(TERMINATED)TerminatedNCT00266812Phase 2Results posted
• Autologous Stem Cell Transplant in Treating Patients With Progressive or Recurrent Hodgkin's LymphomaCompletedNCT00265889Phase 2Results posted
• Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast CancerCompletedNCT00258960Phase 2Results posted
• Rituximab and Cyclophosphamide in Treating Patients With High Risk, Refractory, or Relapsed Multiple MyelomaCompletedNCT00258206Phase 2Results posted
• Cyclophosphamide in Treating Young Patients With Severe Autoimmune EnteropathyCompletedNCT00258180Phase 2Results posted
• Neoadjuvant Biweekly Treatment Followed by Weekly Treatment of Breast CancerCompletedNCT00256243Phase 2Results posted
• Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Hodgkin's LymphomaCompletedNCT00255723Phase 2Results posted
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic CancerTerminatedNCT00255684Not applicableResults posted
• Neoadjuvant Treatment of Breast CancerCompletedNCT00254592Phase 2Results posted
• FCM-R (Fludarabine, Cyclophosphamide, Mitoxantrone, Rituximab) in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL) < 70 YearsCompletedNCT00254410Phase 2Results posted
• Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic SyndromeCompletedNCT00253513Phase 1/2Results posted
• N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk NeuroblastomaCompletedNCT00253435Phase 2Results posted
• Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin's LymphomaTerminatedNCT00248534Phase 2Results posted
• A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 MelanomaCompletedNCT00246012Phase 1/2Results posted
• Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic CancerCompletedNCT00245037Phase 1/2Results posted
• Samarium Sm 153 and Stem Cell Transplant Followed By Radiation Therapy Patients With OsteosarcomaCompletedNCT00245011Phase 2Results posted
• Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's LymphomaCompletedNCT00238433Phase 2Results posted
• S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's LymphomaCompletedNCT00233987Phase 2Results posted
• Adjuvant Radiation Therapy With Ifosfamide in Patients With Mixed Mesodermal Tumors of the UterusCompletedNCT00231842Phase 2Results posted
• Phase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic LeukemiaCompletedNCT00230282Phase 2Results posted
• Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple MyelomaCompletedNCT00217438Phase 3Results posted
• A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell LymphomaCompletedNCT00211185Phase 2Results posted
• Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab Versus Rituximab in MALT LymphomaCompletedNCT00210353Phase 3Results posted
• Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF(Granulocyte-macrophage Colony-stimulating Factor) and RituximabTerminatedNCT00208975Phase 2Results posted
• Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer PatientsCompletedNCT00206518Phase 2Results posted
• Primary Systemic Therapy in Operable/Locally Advanced Breast CancerCompletedNCT00203502Phase 2Results posted
• Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/GlioblastomaCompletedNCT00200161Phase 2Results posted
• Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By SurgeryCompletedNCT00194779Phase 2Results posted
• A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer PatientsCompletedNCT00190671Phase 1/2Results posted
• Natural Killer (NK) Cell Transplantation for AMLCompletedNCT00187096Not applicableResults posted
• Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic LeukemiaCompletedNCT00186875Phase 2Results posted
• Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple MyelomaCompletedNCT00185614Phase 2Results posted
• Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's LymphomasCompletedNCT00184002Phase 2Results posted
• A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular CarcinomaCompletedNCT00183885Phase 2Results posted
• Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast CancerCompletedNCT00182793Phase 2Results posted
• Autologous Transplant for Multiple MyelomaCompletedNCT00177047Phase 2/3Results posted
• Stem Cell Transplantation for HurlerCompletedNCT00176917Phase 2Results posted
• Stem Cell Transplant for Inborn Errors of MetabolismCompletedNCT00176904Phase 2/3Results posted
• Stem Cell Transplant for Bone Marrow Failure SyndromesCompletedNCT00176878Phase 2/3Results posted
• Stem Cell Transplant for Immunologic or Histiocytic DisordersCompletedNCT00176865Phase 2Results posted
• Stem Cell Transplant for HemoglobinopathyCompletedNCT00176852Phase 2/3Results posted
• Stem Cell Transplantation for Hematological MalignanciesTerminatedNCT00176839Phase 2/3Results posted
• T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic DisordersTerminatedNCT00176826Phase 2/3Results posted
• Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate CancerCompletedNCT00176605Phase 2Results posted
• CINJALL: Treatment for Children With Acute Lymphocytic LeukemiaCompletedNCT00176462Phase 2Results posted
• Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis FungoidesCompletedNCT00168064Phase 2Results posted
• Stem Cell Transplantation for Fanconi AnemiaTerminatedNCT00167206Phase 1/2Results posted
• Therapy for Newly Diagnosed Patients With Acute Lymphoblastic LeukemiaCompletedNCT00137111Phase 3Results posted
• Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or MyelodysplasiaCompletedNCT00136084Phase 3Results posted
• Rituximab and Cyclophosphamide Followed by Vaccine Therapy in Treating Patients With Relapsed Hodgkin LymphomaCompletedNCT00134082Phase 1/2Results posted
• Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With OsteosarcomaCompletedNCT00134030Phase 3Results posted
• Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic CancerCompletedNCT00134017Phase 2Results posted
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic CancerCompletedNCT00134004Phase 2Results posted
• Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or LeukemiaCompletedNCT00133991Phase 2Results posted
• Multicenter Uveitis Steroid Treatment (MUST) TrialCompletedNCT00132691Phase 4Results posted
• Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Docetaxel as Neoadjuvant Treatment of Breast Cancer PatientsCompletedNCT00129376Phase 2Results posted
• Combination Chemo, Rituximab, and Bevacizumab in Older Patients With Stage II-IV Diffuse Large B-Cell LymphomaCompletedNCT00121199Phase 2Results posted
• S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed LymphomaTerminatedNCT00121186Phase 2Results posted
• Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast CancerCompletedNCT00119262Phase 2Results posted
• Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV MelanomaCompletedNCT00118274Phase 1/2Results posted
• Scleroderma: Cyclophosphamide or TransplantationCompletedNCT00114530Phase 2/3Results posted
• Temozolomide and Radiation Therapy in Treating Patients With GliomasCompletedNCT00114140Phase 2Results posted
• UARK 2003-25: A Study of Intravenous (IV) Busulfan (Busulfex®) in Multiple Myeloma PatientsTerminatedNCT00113919Phase 1/2Results posted
• S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00109837Phase 2Results posted
• S0433 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's LymphomaCompletedNCT00107380Phase 2Results posted
• S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast CancerCompletedNCT00107276Phase 2Results posted
• Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin DiseaseCompletedNCT00107198Phase 2Results posted
• Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell TumorsCompletedNCT00104676Phase 3Results posted
• Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00103285Phase 3Results posted
• Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell LymphomaCompletedNCT00101101Phase 2Results posted
• Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed GliomasCompletedNCT00100802Phase 2Results posted
• Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or NeuroblastomaCompletedNCT00098865Phase 2Results posted
• Cyclophosphamide, Fludarabine, and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy, Autologous Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Metastatic MelanomaCompletedNCT00096382Phase 2Results posted
• Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung CancerTerminatedNCT00096265Phase 3Results posted
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or TestesCompletedNCT00096135Not applicableResults posted
• Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma (Study P03267)CompletedNCT00091572Phase 3Results posted
• BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)CompletedNCT00088530Phase 3Results posted

← Alkylating agents overview